Temasek Holdings’s Cue Health Inc. Common Stock HLTH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-3,125,000
Closed -$589K 121
2024
Q1
$589K Hold
3,125,000
﹤0.01% 100
2023
Q4
$508K Hold
3,125,000
﹤0.01% 98
2023
Q3
$1.38M Hold
3,125,000
0.01% 74
2023
Q2
$1.15M Hold
3,125,000
0.01% 69
2023
Q1
$5.69M Hold
3,125,000
0.03% 56
2022
Q4
$6.47M Hold
3,125,000
0.04% 59
2022
Q3
$9.41M Hold
3,125,000
0.06% 57
2022
Q2
$10M Hold
3,125,000
0.05% 70
2022
Q1
$20.2M Hold
3,125,000
0.08% 69
2021
Q4
$41.9M Hold
3,125,000
0.15% 56
2021
Q3
$36.9M Buy
+3,125,000
New +$49.2M 0.13% 63

Other funds holding HLTH

Temasek Holdings's HLTH Position: Q2 2024 in Review

Temasek Holdings sold out of Cue Health Inc. Common Stock (HLTH) in Q2 2024, closing a stake of 3,125,000 shares — an estimated $589K sold.

Temasek Holdings first reported a position in HLTH in Q3 2021 and held it in 11 quarters. The position peaked at $41.9M in Q4 2021. 9 funds tracked by Wall St. Rank hold HLTH as of Q2 2024.

  • Temasek Holdings reported no remaining Cue Health Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Temasek Holdings sold 3,125,000 Cue Health Inc. Common Stock shares in Q2 2024, an estimated $589K.
  • Temasek Holdings first reported a position in Cue Health Inc. Common Stock in Q3 2021 and held it in 11 quarters.
  • Temasek Holdings's Cue Health Inc. Common Stock position peaked at $41.9M in Q4 2021.
  • 9 funds tracked by Wall St. Rank held Cue Health Inc. Common Stock as of Q2 2024.

Based on Temasek Holdings's 13F filing for Q2 2024, filed 14 Aug 2024.